Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Melanotan II has been referenced in scientific publications involving peptide science and molecular research
PMID:17306374
Reconstitution volumes and diluent choice for investigational peptides are specified in the trial protocol and IMPD they are not appropriate for individual self-use
Palatin eventually ceased development of Melanotan II in favor of a related compound, bremelanotide (PT-141), which received FDA approval in 2019 for hypoactive sexual desire disorder in women
It agonizes two receptors simultaneously: GLP-1 and GIP, the other major incretin hormone
NAD+ Metabolism in Cardiac Health, Aging, and Disease
US$ 22.48
US$ 23.88
US$ 21.22
US$ 24.48
US$ 28.29
US$ 26.32
US$ 25.76
